COVID-19 AstraZeneca’s Vaxzevria receives full Marketing Authorization in the EU Malin Otmani November 7, 2022
COVID-19 Bavarian Nordic provides update on its COVID-19 booster vaccine candidate Malin Otmani June 21, 2022
COVID-19 New findings on the benefits of mRNA booster vaccines in developing countries Malin Otmani May 16, 2022
COVID-19 1194 Views New study about how the COVID-19 virus binds to cell receptors Malin Otmani August 25, 2021 SARS-CoV-2 can attach to not…
COVID-19 2655 Views AstraZeneca’s PROVENT trial met primary endpoint Malin Otmani August 24, 2021 AZD7442, a combination of two…
COVID-19 1402 Views NextCell files patent application for COVID-19 treatment Malin Otmani August 17, 2021 NextCell Pharma has announced that…
COVID-19 906 Views Vaccine based on Abera’s technology shows good results Malin Otmani August 6, 2021 The vaccine platform developed by…
COVID-19 1624 Views Pfizer-BioNTech’s second dose triggers powerful immune response Malin Otmani August 2, 2021 A new study has revealed…
COVID-19 1282 Views New Danish test determines how long vaccination remains effective Malin Otmani July 28, 2021 A Danish research team has…
COVID-19 2633 Views SynAct Pharma announces positive additional trial data Malin Otmani July 28, 2021 SynAct Pharma has announced additional…
COVID-19 1557 Views New data about one dose of AstraZeneca’s Vaxzevria Malin Otmani July 28, 2021 Real-world data from Canada showed…
COVID-19 1250 Views Two different types of COVID-19 vaccines provide good protection Malin Otmani July 21, 2021 A new study from Umeå…
COVID-19 1504 Views New findings about Vaxzevria’s induced immunity Malin Otmani July 15, 2021 A sub-analysis from the Oxford-led…
COVID-19 1690 Views Vaccibody enters license agreement with Adaptive Biotechnologies Malin Otmani July 14, 2021 Vaccibody has entered into an…
COVID-19 1740 Views Cyxone completes Rabeximod COVID-19 Phase 2 trial Malin Otmani July 14, 2021 The Phase 2 Covid-19 trial…
COVID-19 1400 Views Encouraging results from BerGenBio Malin Otmani July 14, 2021 BerGenBio has presented a combined…
COVID-19 1242 Views Researchers have identified genetic risk factors for severe COVID-19 Malin Otmani July 12, 2021 A comprehensive summary, based on…
COVID-19 1635 Views Vaccibody to initiate a phase 1/2 vaccine trial Malin Otmani June 30, 2021 Vaccibody is initiating a phase…
COVID-19 1458 Views mRNA COVID-19 vaccines may offer protection for years Malin Otmani June 29, 2021 New research shows that Pfizer’s…